News Grower

Independent coverage of AI, startups, and technology.

Ars Technica Jun 25, 2026 at 13:40 Big Tech Rising Hot

New effort will get genome sequences for entire Endangered Species list

Colossal Biosciences will be biobanking tissues from all of them as well.

Signal weather

Rising

Momentum is building quickly, so this card is a good early entry point into the topic.

By John Timmer Original source
New effort will get genome sequences for entire Endangered Species list

The US Endangered Species Act compels the government to identify species at risk of extinction and devise plans to restore populations and the habitats they depend on. It has seen some spectacular successes, such as the restoration of the bald eagle to much of its original range. But over 2,300 plant and animal populations remain on the list, requiring ongoing government intervention. On Thursday, it was announced that all of those species would see their genomes sequenced and tissue samples preserved to aid future conservation efforts. The work will be done by a partnership between two unexpected parties. One is the US government, which has generally attempted to undercut the Endangered Species Act as part of its anti-regulatory efforts. It is joined by Colossal Biosciences, a biotech company that has a controversial take on what actually constitutes a species. Colossal has always said it had a conservation focus, but its headline-grabbing efforts have been directed toward restoring species that have been driven to extinction. It intends to do that by developing a combination of gene editing and reproductive technologies that it expects it can profitably license. But its dire wolf announcement, in which only a tiny handful of genetic changes were edited in to grey wolves, have raised some questions about its seriousness regarding these efforts. Read full article Comments

Stay on the signal

Follow New effort will get genome sequences for entire Endangered Species list

Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.

We send a confirmation link first, then only meaningful digests.

Story map

Understand this topic fast

A quick entry into the story: why it matters now, who is involved, and where to go next for context.

Why it matters now

Fresh coverage with immediate momentum.
There are already 6 connected articles in the same storyline to continue from here.
The story keeps orbiting around Ars Technica, Biobanking, and Biosciences, so the entity pages are the fastest way to build context.
Ars Technica already has 4 follow-up stories on the same theme.

Topic constellation

Open the live map for this story

See which entities, story threads, sources, and follow-up articles shape this story right now.

Click nodes to continue

Entity Cluster Article Hub Source

Story timeline

Continue with this story

A short sequence of events and follow-up stories to understand the arc quickly.

Jun 25, 2026 at 14:40 Ars Technica

Feds deny Polestar authorization to sell cars in US from model year 2027

Unlike with Volvo, there will be no authorization for Polestar to sell its cars here.

Jun 25, 2026 at 14:14 Ars Technica

Apple ratchets up prices, blames the cost of memory

Some Macs are hundreds of dollars more expensive today than yesterday.

Jun 25, 2026 at 13:54 Ars Technica

The "sad inevitability" of Europe's heat wave

Europeans are baking under their second heat wave of the summer.

Jun 25, 2026 at 13:40 Ars Technica

New effort will get genome sequences for entire Endangered Species list

Colossal Biosciences will be biobanking tissues from all of them as well.

Jun 25, 2026 at 10:00 Ars Technica

IBM claims world’s first sub-1 nanometer chip technology

IBM’s nanostack transistors could boost chip performance or energy efficiency.

Jun 24, 2026 at 22:47 Ars Technica

Hotly anticipated Grand Theft Auto VI will cost more than other AAA games

GTA6 might be an outlier, though—at least for now.

How reliable this looks

Signal and trust for Ars Technica

This source works at a rapid pace: 100% of recent stories land in the hot window, and 0% carry visible search signal.

Trusted

Reliability

92

Freshness

100

Sources in storyline

1

Related articles

More stories that share tags, source, or category context.

More from Ars Technica

Fresh reporting and follow-up coverage from the same newsroom.

Open source page